Scaffold and Parasite Hopping: Discovery of New Protozoal Proliferation Inhibitors

被引:22
作者
Singh, Baljinder [1 ]
Bernatchez, Jean A. [2 ]
McCall, Laura-Isobel [2 ]
Calvet, Claudia M. [2 ]
Ackermann, Jasmin [2 ]
Souza, Julia M. [2 ]
Thomas, Diane [2 ]
Silva, Everton M. [2 ]
Bachovchin, Kelly A. [1 ]
Klug, Dana M. [1 ]
Jalani, Hitesh B. [1 ]
Bag, Seema [1 ]
Buskes, Melissa J. [1 ]
Leed, Susan E. [3 ]
Roncal, Norma E. [3 ]
Penn, Erica C. [3 ]
Erath, Jessey [4 ]
Rodriguez, Ana [4 ]
Sciotti, Richard J. [3 ]
Campbell, Robert F. [3 ]
McKerrow, James [2 ]
Siqueira-Neto, Jair L. [2 ]
Ferrins, Lori [1 ]
Pollastri, Michael P. [1 ]
机构
[1] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA
[2] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA
[3] Walter Reed Army Inst Res, Expt Therapeut, Silver Spring, MD 20910 USA
[4] NYU, Sch Med, Dept Microbiol, New York, NY 10010 USA
来源
ACS MEDICINAL CHEMISTRY LETTERS | 2020年 / 11卷 / 03期
基金
美国国家卫生研究院;
关键词
Kinetoplastids; leishmaniasis; Chagas disease; malaria; protozoan parasite inhibitors; parasite-hopping; NEGLECTED TROPICAL DISEASES; DRUG DISCOVERY; LEAD;
D O I
10.1021/acsmedchemlett.9b00453
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Utilizing a target repurposing and parasite-hopping approach, we tested a previously reported library of compounds that were active against Trypanosoma brucei, plus 31 new compounds, against a variety of protozoan parasites including Trypanosoma cruzi, Leishmania major, Leishmania donovani, and Plasmodium falciparum. This led to the discovery of several compounds with submicromolar activities and improved physicochemical properties that are early leads toward the development of chemotherapeutic agents against kinetoplastid diseases and malaria.
引用
收藏
页码:249 / 257
页数:9
相关论文
共 15 条
  • [1] Heart Failure in South America
    Alcides Bocchi, Edimar
    [J]. CURRENT CARDIOLOGY REVIEWS, 2013, 9 (02) : 147 - 156
  • [2] Improvement of Aqueous Solubility of Lapatinib-Derived Analogues: Identification of a Quinolinimine Lead for Human African Trypanosomiasis Drug Development
    Bachoychin, Kelly A.
    Sharma, Amrita
    Bag, Seema
    Klug, Dana M.
    Schneider, Katherine M.
    Singh, Baljinder
    Jalani, Hitesh B.
    Buskes, Melissa J.
    Mehta, Naimee
    Tanghe, Scott
    Momper, Jeremiah D.
    Sciotti, Richard J.
    Rodriguez, Ana
    Mensa-Wilmot, Kojo
    Pollastri, Michael P.
    Ferrins, Lori
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (02) : 665 - 687
  • [3] Antiparasitic Lead Discovery: Toward Optimization of a Chemotype with Activity Against Multiple Protozoan Parasites
    Devine, William
    Thomas, Sarah M.
    Erath, Jessey
    Bachovchin, Kelly A.
    Lee, Patricia J.
    Leed, Susan E.
    Rodriguez, Ana
    Sciotti, Richard J.
    Mensa-Wilmot, Kojo
    Pollastri, Michael P.
    [J]. ACS MEDICINAL CHEMISTRY LETTERS, 2017, 8 (03): : 350 - 354
  • [4] Protozoan Parasite Growth Inhibitors Discovered by Cross-Screening Yield Potent Scaffolds for Lead Discovery
    Devine, William
    Woodring, Jennifer L.
    Swaminathan, Uma
    Amata, Emanuele
    Patel, Gautam
    Erath, Jessey
    Roncal, Norma E.
    Lee, Patricia J.
    Leed, Susan E.
    Rodriguez, Ana
    Mensa-Wilmot, Kojo
    Sciotti, Richard J.
    Pollastri, Michael P.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (14) : 5522 - 5537
  • [5] Anilinoquinoline based inhibitors of trypanosomatid proliferation
    Ferrins, Lori
    Sharma, Amrita
    Thomas, Sarah M.
    Mehta, Naimee
    Erath, Jessey
    Tanghe, Scott
    Leed, Susan E.
    Rodriguez, Ana
    Mensa-Wilmot, Kojo
    Sciotti, Richard J.
    Gillingwater, Kirsten
    Pollastri, Michael P.
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2018, 12 (11):
  • [6] Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need
    Field, Mark C.
    Horn, David
    Fairlamb, Alan H.
    Ferguson, Michael A. J.
    Gray, David W.
    Read, Kevin D.
    De Rycker, Manu
    Torrie, Leah S.
    Wyatt, Paul G.
    Wyllie, Susan
    Gilbert, Ian H.
    [J]. NATURE REVIEWS MICROBIOLOGY, 2017, 15 (04) : 217 - 231
  • [7] Gyapong JO, 2016, NEGLECT TROP DIS, P1, DOI 10.1007/978-3-319-25471-5_1
  • [8] Hit and lead criteria in drug discovery for infectious diseases of the developing world
    Katsuno, Kei
    Burrows, Jeremy N.
    Duncan, Ken
    van Huijsduijnen, Rob Hooft
    Kaneko, Takushi
    Kita, Kiyoshi
    Mowbray, Charles E.
    Schmatz, Dennis
    Warner, Peter
    Slingsby, B. T.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2015, 14 (11) : 751 - 758
  • [9] Repurposing strategies for tropical disease drug discovery
    Klug, Dana M.
    Gelb, Michael H.
    Pollastri, Michael P.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (11) : 2569 - 2576
  • [10] Emerging and Reemerging Neglected Tropical Diseases: a Review of Key Characteristics, Risk Factors, and the Policy and Innovation Environment
    Mackey, Tim K.
    Liang, Bryan A.
    Cuomo, Raphael
    Hafen, Ryan
    Brouwer, Kimberly C.
    Lee, Daniel E.
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 2014, 27 (04) : 949 - 979